Skip to content
Lower risk Medical device recall · FDA · Published January 2, 2024

Philips Allura Xper Interventional Fluoroscopic X-ray Systems Recall: DIMMs May Cause

Philips recalls specific Allura Xper Interventional Fluoroscopic X-ray Systems with DIMMs that may stop functioning, causing procedure delays. Affected models include Allura Xper FD10, FD10/10, FD10C, FD20, and FD20/20 series with listed serial numbers.

🇺🇸 FDA recall #Z-1156-2024Medical devicePHILIPS ›
Take action

Contact the company

Recalling firmPHILIPS MEDICAL SYSTEMS NEDERLAND B.V.Veenpluis 4-6 · Best, Netherlands
✎ GovInfoNow plain-language explainer

Philips is recalling certain Allura Xper Interventional Fluoroscopic X-ray Systems because the Dual In-line Memory Modules (DIMMs) may not work properly, which can cause imaging to stop and delay medical procedures. This affects specific models with particular serial numbers. Read more at govinfonow.com/recall/56436-philips-allura-xper-interventional-fluoroscopic-x-ray-systems-recall-dimms.

Source Summary by GovInfoNow · govinfonow.com/recall/56436-philips-allura-xper-interventional-fluoroscopic-x-ray-systems-recall-dimms · Updated August 19, 2026 · FDA enforcement record: FDA #Z-1156-2024

Cite this page

“Philips Allura Xper Interventional Fluoroscopic X-ray Systems Recall: DIMMs May Cause.” GovInfoNow, updated August 19, 2026. https://govinfonow.com/recall/56436-philips-allura-xper-interventional-fluoroscopic-x-ray-systems-recall-dimms. Based on FDA recall #Z-1156-2024 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1156-2024%22&limit=1).

The FDA announced on Jan. 2, 2024, that Philips Medical Systems Nederland B.V. is recalling Dual In-line Memory Modules (DIMMs) for Philips Allura Xper Interventional Fluoroscopic X-ray Systems due to a potential failure hazard. The agency stated the faulty components may cause the system to stop functioning and imaging to become impossible. Owners should contact Philips for repair or replacement details.

How to tell if you have it

  • Brand: PHILIPS
  • Product: Philips Allura Xper Interventional Fluoroscopic X-ray Systems DIMMs
  • Model/Serial Numbers: Allura Xper FD10 (722003, 722010, 722026), FD10/10 (722005, 722011, 722027), FD10C (722001), FD20 (722006, 722012, 722028), FD20 Biplane (722008, 722013), FD20 Biplane OR Table (722025), FD20 OR Table (722023, 722035), FD20/10 (722029), FD20/15 (722058), FD20/20 (722038), FD20/20 OR Table (722039) with specific UDI-DI and Serial Numbers listed in the record
  • Quantity: 1,681 units in the United States

The hazard

According to the FDA, the Dual In-Line Memory Modules may not perform as intended. This failure can cause the system to stop functioning and imaging to become impossible, resulting in a delay of procedure.

Context

GovInfoNow's records show Philips Medical Systems Nederland B.V. has 58 other recalls on record since May 26, 2021. Other recent recalls of similar products include Philips Brilliance CT 64 Medical Scanner Recall (Aug. 7, 2026), Philips Achieva 3.0T MRI Recalled (Aug. 21, 2026), and GE Optima XR200amx Mobile Radiography System Recall (June 5, 2026).

How to tell if you have this one

Check if your system is an Allura Xper model with the specific model numbers listed (e.g., FD10, FD10/10, FD10C, FD20, FD20/20) and the corresponding serial numbers provided in the recall notice.

  • Brand
    PHILIPS
  • Category
    Medical device
Based on the official FDA remedy

What to do — step by step

  1. Check System Model

    Identify your system model from the list of affected Allura Xper models (e.g., FD10, FD10/10, FD10C, FD20, FD20/20) and verify the serial numbers provided in the recall.

Where it went and when

Where it was distributed

Distributed nationwide and abroad; the notice names 48 states.

Alaska: named in the noticeAKMaine: named in the noticeMEVermont: named in the noticeVTNew Hampshire: named in the noticeNHWashington: named in the noticeWAIdaho: named in the noticeIDMontana: named in the noticeMTNorth Dakota: named in the noticeNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: named in the noticeWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: named in the noticeRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: named in the noticeNVWyoming: named in the noticeWYSouth Dakota: nationwideSDIowa: named in the noticeIAIndiana: named in the noticeINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: named in the noticeCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: nationwideNEMissouri: named in the noticeMOKentucky: named in the noticeKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: named in the noticeDEArizona: named in the noticeAZNew Mexico: named in the noticeNMKansas: named in the noticeKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: named in the noticeSCDistrict of Columbia: named in the noticeDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFL

FDA distribution: “Worldwide Distribution: US nationwide including states of: AL, AK, AR, AZ, CA, CO, CT, DC, DE, FL, GA, HI, IA, ID, IL, IN, KS, KY, LA, MA, MD, ME, MI, MN, MO, MS, MT, NC, ND, NH, NJ, NM, NV, NY, OH, OK, OR, PA, RI, SC, TN, TX, UT, VA, VT,…” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming.

Recall timeline

FDA published this recall 57 days after the firm started it.

1. Firm started the recall: Jan 2, 202412. FDA classified it Class II: Feb 16, 202423. Published in FDA’s Enforcement Report: Feb 28, 202432024
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-1156-2024 (January 2, 2024) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1156-2024 to see it in context.
  • Plain-language summary written by qwen3:4b on August 19, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA